These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27613775)

  • 1. HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.
    Popescu I; Drummond MB; Gama L; Lambert A; Hoji A; Coon T; Merlo CA; Wise RA; Keruly J; Clements JE; Kirk GD; McDyer JF
    J Infect Dis; 2016 Nov; 214(10):1520-1530. PubMed ID: 27613775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.
    Popescu I; Drummond MB; Gama L; Coon T; Merlo CA; Wise RA; Clements JE; Kirk GD; McDyer JF
    Am J Respir Crit Care Med; 2014 Oct; 190(7):744-55. PubMed ID: 25137293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy.
    Baker CA; Emenyonu N; Ssewanyana I; Jones NG; Elrefaei M; Nghania F; Nakiwala J; Andia I; Clark R; Martin J; Bangsberg DR; Cao H
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):900-5. PubMed ID: 17678474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects.
    Neff CP; Chain JL; MaWhinney S; Martin AK; Linderman DJ; Flores SC; Campbell TB; Palmer BE; Fontenot AP
    Am J Respir Crit Care Med; 2015 Feb; 191(4):464-73. PubMed ID: 25536276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
    Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
    J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.
    Freeman ML; Mudd JC; Shive CL; Younes SA; Panigrahi S; Sieg SF; Lee SA; Hunt PW; Calabrese LH; Gianella S; Rodriguez B; Lederman MM
    Clin Infect Dis; 2016 Feb; 62(3):392-6. PubMed ID: 26400999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy.
    Alexandrova Y; Yero A; Olivenstein R; Orlova M; Schurr E; Estaquier J; Costiniuk CT; Jenabian MA
    Respir Res; 2024 Jun; 25(1):240. PubMed ID: 38867225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
    Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
    Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
    Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
    PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of CD4(+) and CD8(+) T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking.
    Jackutė J; Žemaitis M; Pranys D; Šitkauskienė B; Miliauskas S; Bajoriūnas V; Sakalauskas R
    Medicina (Kaunas); 2015 Nov; 51(5):263-71. PubMed ID: 26674143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.